Real Chemistry acquires Spurwing Communications to establish APAC hub in Singapore

Singapore — Real Chemistry has acquired Singapore-based Spurwing Communications, marking a major step in its international growth strategy by establishing its first Asia Pacific (APAC) strategic hub.

The acquisition strengthens Real Chemistry’s presence in one of the world’s fastest-growing healthcare markets while expanding its ability to support pharmaceutical and healthcare organisations across the region through integrated communications, analytics, medical affairs, and AI-powered capabilities.

With the new Singapore hub, Real Chemistry aims to deliver more connected, insight-led, and locally relevant communications that help healthcare brands better engage healthcare professionals, patients and caregivers throughout APAC.

As part of the acquisition, Emma Thompson, Founder and CEO of Spurwing Communications, has been appointed President, APAC Growth at Real Chemistry. She will continue leading the Singapore business while driving the company’s regional expansion and reporting to Kath Harrison, Group President for International Growth at Real Chemistry. 

Founded in Singapore, Spurwing Communications has built a strong reputation for advising pharmaceutical, healthcare, and corporate clients across Asia Pacific through strategic communications and medical affairs expertise.

The acquisition also enables Spurwing’s clients to access Real Chemistry’s global capabilities, including AI-powered audience analytics, medical communications, advertising, and integrated healthcare marketing solutions.

According to Harrison, the acquisition reinforces Real Chemistry’s commitment to investing in high-growth healthcare markets while helping clients deliver more data-driven and culturally relevant engagement across the region.

“APAC is fast becoming one of the most dynamic and strategically important regions for  healthcare innovation and access to life-improving therapies,” said Harrison. “By bringing Spurwing into Real Chemistry, we’re expanding our presence in the region and deepening our ability to help clients drive measurable impact by delivering more connected, data-driven and  culturally relevant engagement across these key markets.”

“Joining Real Chemistry allows us to broaden what we can offer clients, while staying grounded in the strong regional expertise and senior counsel for which our clients value us,” said Thompson. “I’m extremely proud of what we have achieved as a team and excited for the next phase of our growth as part of Real Chemistry.”

“We will continue to support our existing clients while expanding our APAC presence and adding capabilities — including analytics and AI — to enhance our connected, comprehensive regional offerings,” added Thompson. 

Real Chemistry CEO Shankar Narayanan added that expanding the company’s APAC footprint supports its broader global commercialisation strategy, allowing clients to benefit from integrated support across every stage of the healthcare communications journey.

“We’re continuing to invest in the capabilities and regions that matter most to our clients as they navigate growing global commercialization challenges. Strengthening our presence in APAC allows us to better support clients across the full lifecycle — from strategy through engagement — in one of the most dynamic healthcare markets in the world,” said Narayanan. 

Looking ahead, Real Chemistry plans to expand its regional operations further, with additional hires and market expansion initiatives expected across APAC in the coming months.